Implantation of Continent Catheterizable Channel : Native Bladder or Enterocystoplasty ?
NCT ID: NCT04922437
Last Updated: 2021-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
106 participants
OBSERVATIONAL
2020-01-01
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
METHODS. Retrospective monocentric study of pediatrics and adult patients who underwent a continent cystostomy between 1991 and 2020 with a continent catheterizable channel implanted in the native bladder's detrusor (D group) or the enterocystoplasty (EC group).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Filling and Emptying Cystometries ("Backwards Cystometry"): a Feasibility and Validation Study
NCT03255421
Connected Catheter Clinical Feasibility Study( CFS)
NCT03405285
Can Dynamic Ultrasonography Replace Urodynamics in Follow-up of Patients With Myelomeningocele
NCT03550898
Role of Residual Urine and Asymptomatic Prostatitis in the Development of Urinary Tract Infections in Spinal Cord Injury
NCT01601041
The Outcome of Pre-transplant Bladder Cycling in Patients With Defunctionalized Bladder
NCT06787092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The CCC were made from the appendix, an ileal or sigmoid segment, an ureter or a skin flap. Bladder augmentation and cervicoplasty (Kropp, Kurzrock, Young-Dees, artificial urinary sphincter, sling suspension of the bladder neck, closure of the bladder neck) were frequently associated.
The following informations were obtained in all included patients by charts reviews: age at surgery, gender, main underlying pathology, details of operative reports with the type of channel, bladder augmentation and/or associated cervicoplasty, early postoperative complications, complications appearing during the follow up period and the requirement of surgical or non-surgical revision, finally the channel continence at the last follow up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enterocystoplasty (EC)
Patients who had an implantation of the catheterizable continent channel by seromuscular plicature on the anterior wall of the bladder augmentation.
Enterocystoplasty implantation
Continent catheterizable channel implanted by seromuscular plicature on the front wall of the bladder augmentation
Detrusor (D)
Patients who had an implantation of the catheterizable continent channel in the detruosr of their native bladder (Lich-Gregoir or Cohen).
Native bladder implantation
Continent catheterizable channel implanted in the detrusor of the native bladder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Native bladder implantation
Continent catheterizable channel implanted in the detrusor of the native bladder
Enterocystoplasty implantation
Continent catheterizable channel implanted by seromuscular plicature on the front wall of the bladder augmentation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 1991 and 2020
* In the pediatric surgery or urology department at Nancy University Hospital
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pierre LECOANET
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Lecoanet
Role: PRINCIPAL_INVESTIGATOR
CHRU Nancy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pierre Lecoanet
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020PI311
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.